Paracoccidioides brasiliensis is a thermal dimorphic fungus which at host environment exhibits a multinucleated and multibudding yeast form. The cellular and molecular mechanisms underlying these phenotypes remain to be clarified, mostly due to the absence of efficient classical genetic and molecular techniques. Here we describe a method for gene expression knockdown in P. brasiliensis by antisense RNA (aRNA) technology taking advantage of an Agrobacterium tumefaciens-mediated transformation (ATMT) system. Together, these techniques represent a reliable toolbox that can be employed for functional genetic analysis of putative virulence factors and morphogenic regulators, aiming to the identification of new potential drug targets. Paracoccidioides brasiliensis is the etiological agent of Paracoccidioidomycosis, one of the most prevalent systemic mycosis in Latin America. As a thermal dimorphic fungus, P. brasiliensis switches from the environmental mycelial/conidial nonpathogenic form at ambient temperatures to the pathogenic multiple budding yeast form when exposed to temperatures similar to those of the mammalian host (1). The absence of effective molecular techniques has significantly hampered studies in P. brasiliensis relevant for understanding the biology of this fungus as well as the mechanisms that underlie its pathogenicity. We herein report an efficient gene expression knockdown protocol for P. brasiliensis by taking advantage of Agrobacterium tumefaciens-mediated transformation (ATMT) for single-copy genetic integration (PbATMT) developed by our group (3, 5).
Paracoccidioides brasiliensis is the etiological agent of Paracoccidioidomycosis, one of the most prevalent systemic mycosis in Latin America. As a thermal dimorphic fungus, P. brasiliensis switches from the environmental mycelial/conidial nonpathogenic form at ambient temperatures to the pathogenic multiple budding yeast form when exposed to temperatures similar to those of the mammalian host (1) . The absence of effective molecular techniques has significantly hampered studies in P. brasiliensis relevant for understanding the biology of this fungus as well as the mechanisms that underlie its pathogenicity.
We herein report an efficient gene expression knockdown protocol for P. brasiliensis by taking advantage of Agrobacterium tumefaciens-mediated transformation (ATMT) for single-copy genetic integration (PbATMT) developed by our group (3, 5) .
ATMT makes use of a natural transformation process induced by A. tumefaciens, a bacterial plant pathogen that randomly inserts the transfer-DNA (T-DNA) into the plant genome during infection (2) . Fungal ATMT presents advantages over other methods (4) as it (1) shows high efficiency and simplicity, (2) avoids timeconsuming steps and specialized equipment, and (3) can be easily applied in Biosafety Level 3 (BSL3) microorganisms.
Furthermore, we and others have applied this PbATMT system to modulate gene expression in P. brasiliensis using antisense-RNA (aRNA) technology with high success (5, 13) . This has proved to be a proficient genetic system for fungi whose homologous recombination machinery is still poorly described (6), such as P. brasiliensis, as contrary to other allelic replacement strategies, since aRNA "knocksdown" gene expression rather than "knocking-out" an entire gene.
PbATMT and aRNA technology merge as important molecular tools to study functional genetics in P. brasiliensis and advancing research in a field that has previously been lacking this type of technology.
All solutions must be prepared using ultrapure water and analytical grade reagents and stored at room temperature (unless indicated otherwise). Sterilize all the culture medium by autoclaving for 20 min at 121°C. Dispose of all waste materials according to safety regulations.
Escherichia coli strain: JM109 competent cells (Promega).
2. E. coli culture medium (1 L) Luria Bertani (LB): 10 g tryptone peptone, 5 g yeast extract, 10 g NaCl. Suspend the reagents in distilled or deionized water. Adjust to pH 7.0 with NaOH.
3. Plasmids: pCR35 plasmid containing the green fluorescent protein (GFP) gene downstream from the Histoplasma capsulatum calcium-binding protein (CBP1) promoter (7); pUR5750 parental vector for the insertion of recombinant transfer DNA (T-DNA) in P. brasiliensis, harboring an E. coli hygromycin B phosphotransferase (HPH) gene driven by the Aspergillus nidulans glyceraldehyde 3-phosphate (GPD) promoter and transcriptional terminator (TRPC) from pAN7-1 (8).
4. LB medium for positive selection of the clones harboring the pCR35 and pUR5750 constructs: To LB (Subheading 2.1, item 2) add 16 g purified agar. Autoclave. When the medium is cooled to ~50°C, add kanamycin to a final concentration of 50 mg/mL. 9. Neubauer-counting chamber.
T4 DNA ligase (Fermentas
10. 100 mg/mL Cefotaxime stock solution made in ultrapure sterile water, filter sterilized and stored at −20°C.
11. BHI selective medium: add Hygromycin B (Invitrogen) to a final concentration of 50 mg/mL.
1. Lysis Buffer: 1 mM EDTA, 10 mM Tris-HCl (set the pH to 8 with NaOH), 1% SDS, 100 mM NaCl.
2. JETquick Blood and cell culture DNA spin kit (Genomed).
3. 1:1 Phenol/chloroform solution.
Trizol (Invitrogen).
2. DyNAmo cDNA Synthesis Kit (Finnzymes).
DyNAmo SYBR Green (Finnzymes).
Perform all steps of this protocol at room temperature unless specified otherwise. 2. Design primers for the amplification of several aRNA sequences from the 5¢ UTR and coding-sequence regions of the gene of interest ( Fig. 1 ) (see Note 4) . Add an AscI restriction site to the primer binding to the 3¢ end of the sequence and an XhoI restriction site to the primer binding to the 5¢ end of the sequence (see Note 5).
3. Amplify the aRNA sequences using a standard PCR protocol and a proofreading DNA polymerase (see Note 6).
4. Digest pCR35 plasmid and the aRNA PCR amplicons from Subheading 3.1, step 3 separately with AscI and XhoI restriction enzymes, preparing a mix containing 2 mL of 10× FastDigest buffer (Fermentas), 1 mL of each restriction enzyme (Fermentas), ~1 mg of plasmid DNA, or ~0.2 mg of PCR product, and add water up to 20 mL. Incubate at 37°C for 1 h.
5. Clean the product using a column-based DNA purification method (QIAquick PCR purification Kit, Qiagen) following the kit manufacturer's instructions.
6. Ligate each AscI-XhoI-digested aRNA amplicon individually into the AscIXhoI sites of plasmid pCR35, using T4 DNA ligase (Fermentas). Prepare a mix containing 1 mL of ligase, 2 mL of 10× T4 DNA Ligase buffer, 3:1 PCR product/Plasmid DNA ratio, and water to 20 mL. Incubate 1 h at 22°C.
7. Transform E. coli competent cells (Promega) by heat shock following kit manufacturer's instructions, using the mix from Subheading 3.1, step 6. Confirm the presence of constructs in transformants by colony-PCR with exogenous primers p1 and p2 (see Note 7).
8. Isolate plasmid DNA from positive E. coli strains and confirm the presence of constructs by diagnostic restrictive endonuclease treatment of purified plasmid using AscI and XhoI (see Subheading 3.1, step 4).
9. Amplify the DNA fragment from the plasmid harboring the CBP1 promoter, each aRNA sequence, and the terminator using a standard PCR protocol, a proofreading DNA
[AU2] polymerase, and exogenous primers p1 and p2 carrying KpnI restriction sites (see Notes 6 and 7).
10. Digest the DNA fragments with KpnI restriction enzyme (see Subheading 3.1, step 4) and clean the product using a columnbased DNA purification method (see Subheading 3.1, step 5).
11. Digest plasmid pUR5750 with KpnI (see Subheading 3.1, step 4).
12. Dephosphorylate with shrimp alkaline phosphatase (SAPFermentas) to prevent self-ligation. Prepare a mix containing 2 mL of 10× Reaction Buffer (Fermentas), 1 mL (1 U) of SAP enzyme (Fermentas), ~1 mg of plasmid DNA, and add nuclease-free water up to 20 mL. Incubate at 37°C for 30 min. Stop the reaction by heating the mix for 15 min at 65°C.
13. Clone each construct individually into KpnI-digested plasmid ( Fig. 2 ) with T4 DNA ligase (see Subheading 3.1, step 5).
14. Transform E. coli competent cells by heat shock following kit manufacturer's instructions, using the mix from Subheading 3.1, step 13. Confirm the presence of the constructs in transformants by colony-PCR using specific exogenous primers p3 and p4 (see Note 8) and by diagnostic restrictive endonuclease treatment of purified plasmid (see Subheading 3.1, step 4).
15. Isolate the pUR5750 vector harboring the T-DNA constructs for aRNA knockdown using a column-based plasmid purification method (see Subheading 3.1, step 1) (see Note 9).
1. Inoculate an LC plate (without antibiotics) with A. tumefaciens and incubate for 3 days at 29°C.
2. Inoculate bacteria into 2 mL of LC medium and incubate at 29°C for 6 h with agitation (180 rpm).
3. Inoculate 100 mL of LC medium supplemented with 0.1% glucose with 100 mL of the preculture. Grow the cells overnight at 29°C with shaking at 220 rpm to an OD 660 of 1.0-1.5.
4. Chill the culture on ice for 15 min and harvest the cells by centrifugation in a cold rotor at 4,000 × g for 20 min.
[AU3] 5. Resuspend the pellet in 10 mL of 1 mM HEPES (pH 7) and centrifuge as above. Repeat this washing step three times.
Preparation of Ultracompetent
6. Wash the pellet in 10 mL of 10% glycerol solution.
7. Resuspend the pellet in 10% glycerol solution to a final volume of 500-750 mL. The cell concentration is optimally around 1-5 × 10 11 cells/mL.
8. Make 40 mL aliquots of the bacterial suspension in sterile 1.5 mL eppendorfs, freeze immediately in liquid nitrogen, and store at −80°C. The cells can be retained for electroporation for at least a year under these conditions without significant loss of transformation efficiency (12).
1. Gently thaw one aliquot of cells per aRNA product on ice (10-15 min).
2. Chill the electroporation cuvettes on ice.
3. Add 1-5 mL of plasmid DNA (pUR5750) harboring a single T-DNA construct for aRNA (10 ng) to 40 mL of cell suspension and gently mix well.
Transfer the mixture to a prechilled electroporation cuvette.
Ensure that the suspension is in contact with both electrodes of the cuvette.
5. Apply an electric pulse at 2.5 kV, 25 mF, and 200 W. This should result in a pulse of 12.5 kV/cm with a time constant of approx. 4.7 ms.
6. Immediately add 1 mL of SOC medium, and gently but quickly resuspend the cells with a sterile Pasteur pipette.
7. Transfer the cell suspension to a 1.5-mL Eppendorf sterile tube and incubate at 29°C for 1-1.5 h with vigorous shaking (180 rpm).
8. Plate 100 mL aliquots of dilutions on A. tumefaciens selection medium (see Subheading 2.3).
9. Incubate for 3 days at 29°C.
1. Grow A. tumefaciens LBA1100 for 12-18 h carrying the desired knockdown vector or carrying empty vector in liquid LC selection medium with antibiotics (see Subheading 2.4, step 3) in a water bath, at 28°C with shaker (180 rpm) (for maintenance, use identical solid medium at 28-30°C). Be sure that the temperature is stable and exactly at 28°C. 8. Air dry in a safety cabinet with the lights off (see Note 3) for ~30 min prior to incubation at 25°C for 3 days. This is a very important step in the transformation process (see Note 12) (Fig. 3 ).
9. Following cocultivation, transfer the membranes, using a sterile set of tweezers, to 15-mL falcon tubes containing 2 mL of nonselective BHI liquid medium containing 200 mg/mL cefotaxime, and dislodge cells using a sterile loop and vortexing for 1 min. After vortexing, leave the caps of the falcon tubes slightly loose to permit aeration. Allow the cells to recover by incubating the suspension for 48 h at 36°C with shaking at 200 rpm. Spin down the culture (4 min at 2,400 × g, room temperature), remove the supernatant and plate the cells on BHI selective medium containing 50 mg/mL Hygromycin B (see Note 13).
10. Incubate selection plates at 36°C for 15-20 days and monitor for colony formation. 1. Mitotic stability assessment: randomly select Hyg R P. brasiliensis colonies and restreak onto selective BHI solid medium at least three times. Finally, restreak the transformants onto plates with nonselective medium containing 50 mg/mL Hygromycin B a further three times to confirm mitotic stability. After this step, maintain the clones in selective BHI solid medium, restreaking all clones every 3-5 days until confirmation of transformation.
To confirm transformation by T-DNA, randomly select
Hygromycin-resistant (Hyg R ) transformants.
3. Grow selected transformants cells for 72 h in 100 mL BHI selective medium containing 50 mg/mL Hygromycin B.
4. Extract genomic DNA mixing in an eppendorf 200 mL of each culture and 200 mL of Lysis Buffer. Vortex the samples thoroughly, heat the tubes at 65°C for 45 min, and freeze them immediately at −80°C for 1 h (minimum). Centrifuge the tubes for 15 min, 13,000 rpm, at room temperature. Remove the supernatant for genomic DNA isolation using an appropriate kit (JETquick Blood and cell culture DNA spin Kit, Genomed) following the kit manufacturer's instructions.
5. Test for the presence of T-DNA using a standard PCR protocol for amplification of the HPH gene using total DNA as template (see Note 14) (Fig. 4 ).
1. Extract total RNA from exponentially growing P. brasiliensis yeast cultures (72 h). Spin down 15 mL of the cultures (4 min at 2,400 × g, room temperature) and remove supernatant. Add 1 mL of Trizol (Invitrogen), vortex thoroughly, and proceed with a heat shock treatment (20 min at 65°C followed by 60 min at −80°C) for cellular disruption (see Note 15). The following steps are performed according to Trizol manufacturer's instructions.
2. Perform cDNA synthesis using 0. 16 and 17). Target gene expression level in the knockdown strain is then compared to its expression in the P. brasiliensis strain carrying the empty vector.
1. This system has been successfully employed using P. brasiliensis strains ATCC 60855, Pb18, and PbGarcia.
2. Prepare kanamycin and spectinomycin in ultrapure water, filter sterilized, and store at −20°C.
3. Prepare rifampicin in methanol and store at −20°C or at 4°C for short periods of time to avoid precipitation. Note that this antibiotic is light sensitive.
4. Ensure that the chosen sequences do not contain AscI, XhoI, or KpnI restriction sites. We tested several conditions (different sizes and aRNA location) and no relation was observed between these and efficiency of gene downregulation (5).
Reverse primer with
AscI restriction site sequence shown in bold: 5¢-gcgcggcgcgccnnnnnnnnnnnnnnnnnnnn-3¢; Forward primer with XhoI restriction site sequence shown in bold: 5¢-gcgcctcgagnnnnnnnnnnnnnnnnnnnn-3¢.
6. Proofreading DNA polymerases often need a lower elongation temperature, e.g., 68°C instead of 72°C.
7. Primers for amplification of the CBP1 promoter, each aRNA sequence and terminator, from plasmid pCR35 (with KpnI restriction sites shown in bold): p1 (5¢-ggggtaccccgcggatcacggtatcgatga3¢) and p2 (5¢-ggggtaccccggtacctaggtggatccaat-3¢).
pUR5750
KpnI site external primers: p3 (5¢-gatcggtgcgggcctcttcg-3¢) and p4 (5¢-catgacggccatcatgccaa-3¢).
9. Use a column-based method for plasmid isolation due to the large size and low copy number of the pUR5750 vector. Other methods have been tested (e.g., phenol:chloroform:isopropanol (25:24:1) extraction) and found to have a reduced yield compared to the column-based method.
10. It is essential that yeast inocula derive from cells that have been restreaked on solid-medium every 3-4 days.
11. Each mother cell represents 1 cell; 1 × 10 8 cells/mL correspond to approximately a 3-4 mL pellet obtained from spinning down a 50 mL culture in a 50-mL falcon tube.
12. We strongly recommend testing several drying times of the cocultures on hybond-N membranes (15-45 min) to achieve the best transformation efficiency. 13. Hygromycin concentration might depend on the P. brasiliensis strain or even the type of Hygromycin B used.
Notes
14. HPH confirmation primers: p5 (5¢-gaagtactcgccgatagtgg-3¢) and p6 (5¢-gtcgcggtgagttcaggcat-3¢).
15. Other methods can be used (e.g., phenol:chloroform:isopropanol (25:24:1) extraction) but higher efficiency is achieved using Trizol.
16. TUB2 primers for RT-PCR: 5¢-agccttgcgtcggaacatag-3¢ and 5¢-acctccatccaggaactcttca-3¢ (5).
17. Knockdown efficiency for the target gene is evaluated by measuring the reduction in gene expression in the knockdown strain in comparison to the wild-type strain. Other effects of gene knockdown might be assessed by analyzing phenotypical and physiological effects or by analyzing gene expression of genes regulated by the knockdown target gene.
